Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, Yung Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, Wei Yu Chen, Lei Fang, Paul Hynes, Yao Yu Hsieh, Yen Nien Liu, Jiaoti Huang, Kathleen Kelly

Research output: Contribution to journalComment/debatepeer-review

2 Citations (Scopus)

Abstract

This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Original languageEnglish
Pages (from-to)32403
Number of pages1
JournalOncotarget
Volume9
Issue number64
DOIs
Publication statusPublished - Aug 17 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994'. Together they form a unique fingerprint.

Cite this